CD1a ANTIBODIES AND USES THEREOF

Antibodies to programmed cell death protein 1

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

ANTIBODIES TARGETING G-PROTEIN COUPLED RECEPTOR AND METHODS OF USE

CXCL10 BINDING PROTEINS AND USES THEREOF

ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF

ANTI-PT217 TAU ANTIBODY

NEUTRALIZING ANTI-INFLUENZA B ANTIBODIES AND USES THEREOF

ANTI-PD-1 ANTIBODY-ATTENUATED IL-2 IMMUNOCONJUGATES AND USES THEREOF

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY

ANTI-FENTANYL ANTIBODIES

ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF

Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject

Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

Antibody variable domains targeting the NKG2D receptor

MICA/B ANTIBODIES AND METHODS OF USE

ANTI-PD-L1 ANTIBODIES AND FUSION PROTEINS THEREOF

MONOCLONAL ANTIBODY AGAINST HUMAN LAG-3, METHOD FOR PREPARING SAME, AND USE THEREOF

Compositions and Methods for Treating Cancer with Anti-CD19 Immunotherapy

ANTI-SIGLEC-9 ANTIBODIES AND METHODS OF USE THEREOF

NANOBODY TO GLYCOPROTEIN VI

Methods and Compositions for Targeting Polyubiquitin

ANTI-TAU ANTIBODIES AND METHODS OF USE

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

Muscle targeting complexes and uses thereof for treating dystrophinopathies

ANTI-CD47 ANTIBODIES AND USES THEREOF

CANINE DISTEMPER VIRUS HEMAGGLUTININ AND FUSION POLYPEPTIDES

ANTI-TL1A ANTIBODIES AND METHODS OF USE THEREOF

ENGINEERED MULTI-SPECIFIC ANTIBODIES AND RELATED METHODS OF USE AND MANUFACTURE

BISPECIFIC ANTIBODY FOR SPECIFICALLY NEUTRALIZING TGF-B SIGNAL OF HELPER T CELL, AND PHARMACEUTICAL COMBINATION AND USE THEREOF

SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES

BISPECIFIC ANTIBODY WHICH BINDS TO CD40 AND EpCAM

HERV-K Antibody Therapeutics

ANTI-CD20 ANTIBODIES, ANTI-CD37 ANTIBODIES, AND MIXTURES THEREOF

METHODS OF INDUCING IMMUNE TOLERANCE WITH MODIFIED ANTI-CD154 ANTIBODIES

MULTIVALENT BINDING MOLECULES

ANTI-CTLA-4 ANTIBODY AND USE THEREOF

SIALIDASE-PD-1-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF

ENGINEERED DUAL BINDING ANTIBODIES AND USES THEREOF

TAU BINDING COMPOUNDS

SARS-COV(-2) SPIKE GLYCOPROTEIN-BINDING DOMAINS AND POLYPEPTIDES COMPRISING THE SAME AND USE OF THE SAME

ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Animal Models and Therapeutic Molecules

METHODS AND COMPOSITIONS FOR POTENTIATING ANTITUMORAL IMMUNE RESPONSES THROUGH TARGETING OF NTPDASE3

GPC3 ANTIBODY AND APPLICATION THEREOF

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A

ANTI-TFR:PAYLOAD FUSIONS AND METHODS OF USE THEREOF

ANTIBODIES THAT BIND EGFR AND ERBB3

MULTI-PARATOPIC ANTI-PD-1 ANTIBODIES AND USES THEREOF

RECOMBINANT CD3 BINDING PROTEINS AND THEIR USE

TRPV1 EPITOPES AND ANTIBODIES

PRECISION MEDICINE FOR CHOLESTEROL TREATMENT

ANTI-C5 ANTIBODIES AND METHODS OF USE

ANTIBODIES THAT POTENTLY NEUTRALIZE RABIES VIRUS AND OTHER LYSSAVIRUSES AND USES THEREOF

INNATE IMMUNE CELL SILENCING BY SIRP-ALPHA ENGAGER

Anti-human MASP-2 antibody, preparation method therefor and application thereof

HUMANIZED ANTIBODIES AND FRAGMENTS THEREOF BINDING TO CARBOHYDRATE ANTIGENS AND USES THEREOF

Methods for Producing Fabs and IgG Bispecific Antibodies

PREPARATION AND USE OF ANTI-FSHR ANTIBODY AND ANTIBODY-DRUG CONJUGATE THEREOF

PEPTIDE COMPOSITIONS AND METHODS FOR ANTI-CD3 BINDING DOMAINS

ANTI-CD47 MONOCLONAL ANTIBODY AND USE THEREOF

HEAVY CHAIN ONLY ANTIBODIES TO PDGF

Anti-ETEC adhesin protein antibodies and methods of use

SARS-COV-2 ANTIBODIES

Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding Fragments

ANTI-CD19 ANTIBODIES AND CAR-T STRUCTURES

ANTI-ICOS AGONIST ANTIBODIES AND USES THEREOF

Affinity molecules and methods for their use

METHOD FOR GENERATING HIGH AFFINITY ANTIBODIES

HALF-LIFE EXTENDING COMPOSITIONS AND METHODS

HETERODIMERIC IGA FC CONSTRUCTS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING TROP2 AND EFFECTOR CELL ANTIGENS

ANTI-HVEM ANTIBODY, AND COMPOSITION AND METHOD ASSOCIATED WITH SAME

ANTI-PD-1 ANTIBODY AND USE THEREOF

PROTEIN CONTAINING HETERODIMER ANTIBODY FC, AND PREPARATION METHOD THEREFOR

SIRP-α binding proteins and methods of use thereof

AN ANTIBODY AGAINST P-CADHERIN AND USES THEREOF

ANTIBODIES TARGETING COMPLEMENT FACTOR D AND USES THEROF

USE OF REGULATOR OF ITPRIPL1 IN PREPARATION OF DRUG THAT REGULATES IMMUNE RESPONSES OR FIGHTS TUMORS

COMPOSITIONS OF GUANYLYL CYCLASE C (GCC) ANTIGEN BINDING AGENTS AND METHODS OF USE THEREOF

MATERIALS AND METHODS FOR PERFORMING HISTOCHEMICAL ASSAYS FOR HUMAN PRO-EPIREGULIN AND AMPHIREGULIN

ANTIBODIES SPECIFIC FOR QSOX1 AND METHODS OF USING THE SAME

ANTIBODIES AND METHODS OF USE

DEGRADATION OF SURFACE PROTEINS USING BISPECIFIC BINDING AGENT

ANTI-HER3 ANTIBODY AND ANTI-HER3 ANTIBODY-DRUG CONJUGATE AND MEDICAL USE THEREOF

ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY

ANTI-OPG ANTIBODIES

CX3CR1-BINDING POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS

ANTI-HUMAN PD-L2 ANTIBODIES

ANTI-PD-L1/TGF-ß BIFUNCTIONAL ANTIBODY AND USE THEREOF

ILT-BINDING AGENTS AND METHODS OF USE THEREOF

IL-7 binding proteins and their use in medical therapy

Compositions and methods for treating synucleinopathies

IMMUNOGLOBULIN LIGHT CHAIN ANTIBODIES AND USES THEREOF

NPC1 MONOBODIES AND MONOBODY CONJUGATES THEREOF

RECOMBINANT PROTEIN TARGETING PD-1 AND TGFBETA

CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL 13Ra2

MODIFIED IMMUNOGLOBULIN WITH AFFINITY FOR FcGAMMARIIb AND METHOD OF USE THEREOF

ANTI-IgG NANOBODIES

ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR)

AGONISTIC ANTI-IL-2R ANTIBODIES AND METHODS OF USE

AN LTBR AGONIST IN COMBINATION THERAPY AGAINST CANCER

ANTIBODIES BINDING TO CD3 AND PLAP

ANTI-CD200R1 ANTIBODIES AND METHODS OF USE THEREOF

ROR1 BINDING PROTEIN AND USE THEREOF

CD3 BINDING ANTIBODIES

BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3

TESTOSTERONE-SPECIFIC AFFIBODY AND USES THEREOF

ANTIBODIES SPECIFIC TO CCL21 AND METHODS OF USE

Antibodies specific for human complement C5A receptor (C5AR)

Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use

ANTI-TSLP ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF

Antibodies that bind human C6 and uses thereof

NOVEL ANTI-A2AP ANTIBODIES AND USES THEREOF

BISPECIFIC ANTIBODY FOR CLAUDIN 18A2 AND CD3 AND APPLICATION OF BISPECIFIC ANTIBODY

THERAPEUTIC ANTIBODY AND USES THEREOF

ENGINEERED FCRIIB SELECTIVE IGG1 FC VARIANTS AND USES THEREOF

ANTIBODIES THAT BIND TO C-TYPE LECTIN DOMAIN FAMILY 2 MEMBER D (CLEC2D)

BISPECIFIC ANTIBODY AND USE THEREOF

ANTI-CTLA4 AND ANTI-PD-1 BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF

Antibody Constructs for CDH19 and CD3

ROR1-TARGETING ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications

CANINE ANTIBODY VARIANTS

ANTIBODIES AGAINST STREPTOCOCCAL M PROTEIN

Compositions and methods for treating and preventing staphylococcus aureus infections

FUSIONS OF MUTANT INTERLEUKIN-10 POLYPEPTIDES WITH ANTIGEN BINDING MOLECULES FOR MODULATING IMMUNE CELL FUNCTION

METHODS FOR PRODUCING ANTIBODIES

MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 NUCLEOCAPSID PHOSPHOPROTEIN AND SANDWICH ELISA METHOD

MODIFIED NK-92 CELLS FOR TREATING CANCER

Antibodies and Single-Chain Variable Region Proteins Recognizing Click Products

Method of treating cancer using CD137 antibodies and PD-1 antagonists

TrkA antibody and application thereof

ANTIBODIES BINDING SIGLEC15 AND USES THEREOF

FULLY HUMAN ANTIBODY TARGETING CD5, AND FULLY HUMAN CHIMERIC ANTIGEN RECEPTOR (CAR) AND APPLICATION THEREOF

ANTI-TIGIT ANTIBODY, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

Anti-TIGIT Antibody or Antigen-Binding Fragment Thereof

HUMAN ANTI-IL-33 NEUTRALIZING MONOCLONAL ANTIBODY

Combinations of Antibodies and Bispecific Antibodies Comprising Antigen-Binding Specifically Recognizing Pseudomonas PcrV and Psl

Methods and composition for neutralization of influenza

POLYPEPTIDES FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION

COMPOSITIONS AND METHODS FOR RAPID PRODUCTION OF VERSATILE SINGLE DOMAIN ANTIBODY REPERTOIRES

HUMAN ANTIBODIES TO TN ANTIGEN

Tissue factor pathway inhibitor antibodies and uses thereof

FACTOR X BINDERS ENHANCING FX ACTIVATION

ANTI-CD38 ANTIBODIES AND FORMULATIONS

NOVEL CONJUGATE MOLECULES TARGETING CD39 AND TGFBETA

Multivalent and multispecific 41BB-binding proteins

Bispecific antibody binding BCMA and CD3

METHODS OF TREATING SEVERE INSULIN RESISTANCE BY INTERFERING WITH GLUCAGON RECEPTOR SIGNALING

ANTIBODY BINDING HUMAN IL-5R alpha AND USE THEREOF

ALK7 Binding Proteins and Uses Thereof

ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET, AND METHODS OF USE THEREOF

ANTIBODY VARIANTS AGAINST WNT RECEPTOR RYK

ANTI-CD3/ANTI-CD28 BISPECIFIC ANTIGEN BINDING MOLECULES

TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES

ANTI-CD22 NANO ANTIBODY AND USE THEREOF

ANTIBODIES AGAINST INTERLEUKIN-22

TREATMENT OF CANCER USING INHIBITORS OF TGF-BETA AND PD-1

TAU-BINDING ANTIBODIES

CALRETICULIN NANOBODIES

Antibody-peptide fusion proteins for treating amyloid disorders

NEW TYPE II COLLAGEN BINDING PROTEINS

Neutralizing Antibodies that Bind the SARS-COV-2 S Protein

PHARMACEUTICAL COMPOSITION CONTAINING EXOSOME AND PREPARATION METHOD THEREOF

ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS ANTIBODIES

THERAPEUTIC MOLECULES

IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells

IGF1R ANTIBODIES

FC BINDING FRAGMENTS COMPRISING A PD-L1 ANTIGEN-BINDING SITE

IMMUNE CHECKPOINT INHIBITOR

POLYPEPTIDE CONSTRUCTS BINDING TO CD3

BISPECIFIC ANTIBODY BINDING TO CD3

USE OF ANTI-TREM1 NEUTRALIZING ANTIBODIES FOR THE TREATMENT OF MOTOR NEURON NEURODEGENERATIVE DISORDERS

HUMANIZED CD19 ANTIBODY AND USE THEREOF

SARS-COV-2 NUCLEOCAPSID ANTIBODIES

ANTI-CD79B ANTIBODY-DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF

WARS-NEUTRALIZING ANTIBODY AND USE THEREOF

MULTISPECIFIC ANTIBODIES AND USES THEREOF

FC ALPHA RECEPTOR BINDING ANTIBODY

MONOCLONAL ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 PROTEIN AND THEIR USE IN MEDICINE

ANTI-IL5 NANOANTIBODY AND USE THEREOF

METHODS FOR TREATING INFLAMMATION USING ANTIBODIES TO KALLIDIN AND DES-ARG10-KALLIDIN

ANTIBODIES TO CORONAVIRUS SPIKE PROTEIN AND METHODS OF USE THEREOF

ANTI-RSV MONOCLONAL ANTIBODY FORMULATION

Polyomavirus neutralizing antibodies

CANINE ANTIBODY LIBRARIES

ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

METHODS FOR MITIGATING INTERFERENCE BY THERAPEUTIC ANTI-CD47 ANTIBODIES IN PRE-TRANSFUSION ASSAYS

ANTIBODY-LIKE PROTEIN AND USE THEREOF

THERAPEUTIC CEMIP ANTIBODIES

MULTIVALENT MEDITOPES, MEDITOPE-BINDING ANTIBODIES AND USES THEREOF

COMPOSITIONS AND METHODS FOR MUC18 TARGETING

Anti-FcRn antibody or antigen binding fragment thereof with improved stability

Chimeric and Humanized Anti-Human CTLA4 Monoclonal Antibodies and Uses Thereof

INHIBITION OF PLATELET AGGREGATION USING ANTI-HUMAN GPVI ANTIBODIES

LONG ACTING BI-SPECIFIC T CELL ENGAGERS TARGETING CD3 AND CD47

BIFUNCTIONAL ANTAGONISTS OF ACTIVIN AND TUMOR NECROSIS FACTOR ALPHA AND USES THEREOF

NEUTRALIZING ANTIBODY SPECIFIC TO HUMAN DENATURED CRP, AND MEDICINE AND ANTI-INFLAMMATORY AGENT CONTAINING THE SAME

Antibody against Novel Coronavirus, and Reagent and Kit for Detecting Novel Coronavirus

SINGLE DOMAIN ANTIBODIES TARGETING SARS CORONAVIRUS SPIKE PROTEIN AND USES THEREOF

COMPOSITIONS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN AND METHODS THEREOF

METHODS FOR DETECTION OF FOLATE RECEPTOR 1 IN A PATIENT SAMPLE

HIGHLY SENSITIVE PARTICLE ENHANCED ASSAY FOR THE QUANTIFICATION OF NT-PROBNP

ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOF

NANOBODIES BINDING TROP2 AND USES THEREOF

ANTI-CD26 ANTIBODIES AND USES THEREOF

ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS

MOLECULES BINDING PD-L1 AND USES THEREOF

Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)

Antibodies against TIM3 and uses thereof

COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF

MONOCLONAL ANTIBODIES TO GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15), AND USESTHEREOF FOR TREATING CANCER CACHEXIA AND CANCER

FELINE ANTIBODY VARIANTS

C3-BINDING AGENTS AND METHODS OF USE THEREOF

COMPLEMENT FACTOR D ANTAGONIST ANTIBODIES AND CONJUGATES THEREOF

ANTIBODY SPECIFIC FOR SARS-COV-2 RECEPTOR BINDING DOMAIN AND THERAPEUTIC METHODS

MULTIMERIC PROTEIN COMPLEXES AS ANTIBODY SUBSTITUTES FOR NEUTRALIZATION OF VIRAL PATHOGENS IN PROPHYLACTIC AND THERAPEUTIC APPLICATIONS

ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF

SPECIFICY-ENHANCED BISPECIFIC ANTIBODY (SEBA)

METHODS OF PREVENTING OR TREATING INFECTION BY RESPIRATORY VIRUSES INCLUDING SARS-CoV-2

ANTI-TN-MUC1 CHIMERIC ANTIGEN RECEPTORS

ANTI-PSMA ANTIBODIES AND USES THEREOF

ANTI-TROP-2 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF OR MUTANT THEREOF, AND MEDICAL USE THEREOF

BINDING MOLECULES THAT MULTIMERISE CD45

BCMA/TACI ANTIGEN-BINDING MOLECULES

ANTIBODIES SPECIFICALLY RECOGNIZING INTERLEUKIN-4 RECEPTOR ALPHA AND USES THEREOF

ANTI-LILRB1 ANTIBODY AND USES THEREOF

Leptin antibodies and method of reducing leptin

ANTIBODY THAT BINDS TO VEGF-A AND ANG2 AND METHODS OF USE

SINGLE DOMAIN ANTIBODIES THAT TARGET SARS-COV-2

HUMANIZED ANTI-CD22 RECOMBINANT IMMUNOTOXIN AND APPLICATION THEREOF

Anti-MUC1 antibody-drug conjugate

CAR CELLS TARGETING AN INSERTED LIGAND

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

ANTIBODIES CAPABLE OF BINDING TO ROR2 AND BISPECIFIC ANTIBODIES BINDING TO ROR2 AND CD3

ANTI-ERBB3 ANTIBODIES

TRISPECIFIC BINDERS

DUAL SPECIFICITY ANTIBODIES TO HUMAN PD-L1 AND PD-L2 AND METHODS OF USE THEREFOR

NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A

ANTI-LYMPHOTOXIN BETA RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODIES BINDING CD40 AND USES THEREOF

Method of treating type 1 interferon (IFN)-mediated disease using a subcutaneous dosing regimen comprising anifrolumab

COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF

Monoclonal antibodies directed against programmed death-1 protein and their use in medicine

ANTI-CD2 ANTIBODIES

TIM-3-targeting antibodies and uses thereof

Materials And Methods For Binding Siglec-3/CD33

Materials And Methods For Binding Siglec-3/CD33

BISPECIFIC ANTIBODY TREATMENT OF LYMPHOID MALIGNANT NEOPLASM CONDITIONS

ANTI-CD22 ANTIBODY MOLECULE OR ANTIGEN-BINDING FRAGMENT AND USE THEREOF

ANTI-IL31 ANTIBODIES FOR VETERINARY USE

Anti-PfRH5 antibodies and antigen-binding fragments thereof

BINDING PROTEINS AND ANTIGEN BINDING FRAGMENTS THEREOF THAT BIND ABETA

ANTIGEN-BINDING MOLECULES THAT BIND TO PORPHYROMONAS GINGIVALIS

Human immunodeficiency virus neutralizing antibodies and methods of use thereof

SARS-COV-2-BINDING PEPTIDE

REPAIRED THERAPEUTIC AND PROPHYLACTIC ANTIBODIES AGAINST SARS-CoV-2 VARIANTS

METHODS FOR FORMULATING ANTIBODY DRUG CONJUGATE COMPOSITIONS

OPTIMIZED ANTIBODIES TARGETING TROP2 AND USES THEREOF

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME

HUMANIZED ANTIBODY, CHIMERIC ANTIGEN RECEPTOR, NUCLEIC ACID, VECTOR, CELL AND USE

CD45 BINDING MOLECULES AND METHODS OF USE

SINGLE-DOMAIN ANTIBODY TARGETING 4-1BB, FUSION PROTEIN THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF

BISPECIFIC ANTIBODY SIMULTANEOUSLY BINDING TO INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT AND INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT, AND USE THEREOF

PROTEASE CLEAVABLE BISPECIFIC ANTIBODIES AND USES THEREOF

SINGLE DOMAIN ANTIBODIES TO PROGRAMMED CELL DEATH PROTEIN 1 (PD-1)

PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF

TRISPECIFIC ANTI-CD38, ANTI-CD28, AND ANTI-CD3 BINDING PROTEINS AND METHODS OF USE FOR TREATING VIRAL INFECTION

MONOCLONAL ANTIBODIES AND METHODS FOR USING SAME

CD47 BINDING AGENTS AND USES THEREOF

Antigen Binding Molecules Targeting SARS-CoV-2

Antigen binding molecules targeting SARS-CoV-2

COVID-19 ANTIBODIES AND USES THEREOF

IL-21 polypeptides and targeted constructs

Recombinant Fusion Proteins Comprising Interleukin-18-Binding Protein and Antigen Binding Fragment to Serum Albumin, and Compositions and Uses Thereof

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS

BISPECIFIC ANTIBODY

ENGINEERED ANTIBODY MOLECULES TO CD138 AND USES THEREOF

SINGLE-CHAIN FRAGMENT VARIABLE COMPRISING MUTANT LIGHT CHAIN FRAMEWORK REGION

AMH-COMPETITIVE ANTAGONIST ANTIBODY

Anti-ULBP6 antibodies

NOVEL ANTI-PD-1 ANTIBODIES

Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor

Anti-ANGPTL3 antibodies suitable for high concentration compositions and subcutaneous administration

Methods of determining the function of polyubiquitin using anti-polyubiquitin antibodies

MODIFIED FC REGIONS